Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection

Details for Australian Patent Application No. 2007338899 (hide)

Owner Merck & Co., Inc. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.

Inventors Durette, Philippe L.; Gardelli, Cristina; Pacini, Barbara; Meppen, Malte; Narjes, Frank

Agent Spruson & Ferguson

Pub. Number AU-A-2007338899

PCT Pub. Number WO2008/079206

Priority 60/876,034 20.12.06 US

Filing date 14 December 2007

Wipo publication date 3 July 2008

International Classifications

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C07H 19/06 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/079206 Priority application(s): WO2008/079206

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.; Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338907-Carrier less modulator using saw filters

2007338887-Method of obtaining viable small tissue particles and use for tissue repair